Pharmaceutical-grade lithium carbonate is a high-purity compound used primarily in the treatment of bipolar disorder and depression. It plays a crucial role in mood stabilization and neurological health. The growing prevalence of mental health disorders is driving demand, particularly in North America and Europe. The industry is witnessing advancements in purification techniques and regulatory compliance, ensuring high-quality production. Rising R&D in psychiatric treatments and increasing awareness of mental health solutions further boost market growth. The reports 2025 research report offers an analytical view of the industry by studying different factors like pharmaceutical grade lithium carbonate market growth, consumption volume, Market Size, Revenue, Market Share, Market Trends, and top key players analysis with expert review and forecast.
The pharmaceutical grade lithium carbonate market is projected to grow from USD 141 million in 2023 to USD 166 million by 2028, at a CAGR of 3.3% from 2023 to 2028. Pharmaceutical grade lithium carbonate is a drug primarily utilized to treat mood disorders such as bipolar disorder and depression.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146574055
By application, extended releasesegment is estimated to account for the largest market share in 2023.
Certain mental health disorders can experience fluctuations in symptoms when the drug concentration in the body varies. Extended release medications help to smooth out these fluctuations and provide a more constant effect. Also, extended release formulations can be preferred by healthcare providers because they offer a more controlled and predictable drug release profile, making it easier to tailor treatment plans to individual patient needs. All these factors are expected to enhance the demand for extended release pharmaceutical grade lithium carbonate medicines during the forecast period.
North America was the largest region in the pharmaceutical grade lithium carbonate market in 2022, by value.
The development of technology and innovation across several industries are characteristics of North America. Manufacturers of pharmaceutical grade lithium carbonates in the region make huge investment in the research & development to improve the performance qualities of medicines. The pharmaceutical grade lithium carbonate market in North America is expanding as a result of technological developments in pharmaceutical sector and awareness regarding mental health among people. Awareness campaigns and patient advocacy groups focusing on mental health conditions is contributing to enhance the understanding and acceptance of treatment options related to mental illness. This is expected to drive the market for pharmaceutical grade lithium carbonate in the country.
Pharmaceutical Grade Lithium Carbonate Market Companies
The major players operating in the pharmaceutical grade lithium carbonate market include Livent Corporation (US), Albemarle Corporation (US), Jiangsu Lianhuan Pharmaceutical Co., Ltd. (China), American Elements (US), Globe Química (US), Jiangsu Nhwa Pharmaceutical Co., Ltd. (China), Panchsheel Organics Ltd (POLTD) (India), Blanver (Brazil), and others.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=146574055
Livent Corporation
Livent Corporation is engaged in manufacturing good performance product solutions such as energy storage & battery systems, polymers, grease, aerospace, and pharmaceuticals & agrochemicals. Livent operates manufacturing sites in the US, England, India, China, and Argentina. The company is one of the manufacturers of lithium compounds with various performance levels. Its good performance lithium compounds play a crucial role in the manufacture of medicines and polymers as well as existing and future high energy density batteries used in electric car applications. The company has a strong focus in the majority of the global markets for lithium compounds, with significant expansion taking place in Asia, followed by Europe and the US.
Albemarle Corporation
Albemarle Corporation caters to various end markets such as energy storage, petroleum refining, consumer electronics, building, automotive, lubricants, pharmaceuticals, and crop protection. The company aims at maintaining leading positions in the areas of specialty chemicals industry through commercial and geographic diversity, technical know-how, access to resources, global manufacturing base, and strategic focus on core base technologies. Albemarle operates around 25 production and research & development (R&D) facilities. Albemarle Corporation has acquired companies and formed joint ventures as a part of its corporate growth strategy, and it plans to look for acquisition and joint venture opportunities in the future.
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=146574055
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. is engaged in integrating R&D, manufacturing, and sales in the pharmaceutical sector. It offers various products such as urinary system (Eprelide, terazosin), antihistamines (Ebastine Tablets, Terfenadine Tablets), cardiovascular drugs (Felodipine tablets, simvastatin tablets), steroid hormones (levonorgestrel, danazol capsules) and antibiotics (azithromycin tablets, doxycycline hydrochloride tablets). It is one of the major 100 businesses in China’s pharmaceutical sector and has seen a number of advancements. The company has a strong focus on research & development with the formation of two R&D facilities in China.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-grade-lithium-carbonate-market-146574055.html
